COVID-19 and Cardiovascular Disease

Editor's choice

Videos

Webinars

COVID-19

Articles

Podcast Episodes

  • How COVID-19 has changed the educational paradigm - Steve Elias

    How has education and training for physicians changed in light of the COVID-19 pandemic? Steve Elias, MD, meets with key industry figures from AngioDynamics, Philips, Medtronic as well as event organisers, Radcliffe Group, to gain a different perspective, this time from industry on their response to the recent pandemic.

  • Portrait of a clinician-scientist during the COVID-19 Pandemic: Jag Singh MD PhD

    Portrait of a clinician-scientist during the COVID-19 Pandemic: Jag Singh M...

    Jagmeet P Singh, a Professor of Medicine at Harvard Medical School, a renowned Clinical Trialist, and the past Clinical Chief of Cardiology at Massachusetts General Hospital joins Ankur Kalra for a deep conversation about his journey across three continents.

    Dr Singh talks about the importance of choosing fulfillment over success. We gain more insights on the recent late-breaking clinical trial, MADIT-CHIC focusing on cardiac resynchronization therapy. Ankur asks Jag about his experience of being on the other side of the healthcare system as a patient and his participation in an investigational drug study.

     

  • COVID-19: Lessons and Learnings from Italy with Prof Michele Senni

    COVID-19: Lessons and Learnings from Italy with Prof Michele Senni

    “It’s a tsunami not just a wave. The worst tsunami you can imagine”

    Prof Michele Senni is Director of Cardiology at Papa Giovanni XXIII Hospital, Bergamo Italy. He contracted COVID-19 himself and in this latest podcast he meets with Ankur Kalra, MD to discuss his personal experience in dealing with patients and COVID-19 in Europe’s outbreak epicentre.

    Hear them discuss the burden on healthcare, patient selection, the importance of testing and PPE and how COVID has resulted in a reduction of acute myocardial infarction and heart failure in patients.

Dilated Cardiomyopathy Risk in Patients with Coronavirus Disease 2019: How to Identify and Characterise it Early?

Open access
This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.

The novel coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a public health emergency of international concern.1 The pandemic is ongoing, and the world is faced with the urgent task of minimising the mortality associated with COVID-19.

Mechanisms of Myocardial Injury in Coronavirus Disease 2019

Open access
This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.

Coronavirus disease 2019 (COVID-19) has evolved into a global pandemic, having affected more than 2.3 million people and claiming more than 160,000 lives. Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus predominantly causes fever (77–98% of cases), fatigue (52–75%) and cough (60–81%).1,2 While it primarily affects the respiratory system, it also appears to have a unique interplay with the cardiovascular system.